国产成人秘在,国产黄色a级,91麻豆精品国产91久久久久

Cancel

Date：2021-03
http://www.xinyucaifu.cn/index.php?a=shows&catid=34&id=824
Arctic Vision, a clinical-stage biotech company focused on innovative ophthalmology therapies, announced today that it has successfully raised over $100 million in B round financing. The financing was led by Loyal Valley Capital, with participation from T
Cancel

Date：2021-03
http://www.xinyucaifu.cn/index.php?a=shows&catid=34&id=825
Gensciences Group announced the closing of over RMB 800 million in Series A and B financings. The B round financing was led by HT Capital, with participation from Efung Capital and Huarong Rongde. Existing A round shareholders IDG Capital, New Alliance Ca
Cancel

Date：2021-02
http://www.xinyucaifu.cn/index.php?a=shows&catid=34&id=831
On February 24, 2021, YS Biopharma announced the closing of over $130 million in its Series B financing. This round of investment was jointly led by Oceanpine and OrbiMed. Following the Series B financing, the company's institutional investors include Oce
Cancel

Date：2021-02
http://www.xinyucaifu.cn/index.php?a=shows&catid=34&id=826
WuXi Diagnostic rasied $150 million in its Seris B financing, led by Shiyu Investment, Thermo Fisher Scientific, ABC International, Sunland Fund, CCB Sci-Tech Innovation Fund, with continued support from existing shareholder Yunfeng Capital. The funds fro
Cancel

Date：2021-02
http://www.xinyucaifu.cn/index.php?a=shows&catid=34&id=832
As a leading company in radiopharmaceutical targeted diagnosis and treatment, Sinotau Pharmaceutical announced a Series D financing of RMB 320 million. This follows the RMB 280 million raised in Series C financing in July 2020 from investors such as Ruiyi
Cancel

Date：2021-02
http://www.xinyucaifu.cn/index.php?a=shows&catid=34&id=519
Guangzhou Weiyuan (Vision Medicals) Gene Technology Co., Ltd. (hereinafter referred to as “Vision Medicals” or the “Company”), a leader in the infection precision medicine industry, recently announced the completion of a Series B financing round of several hundred million RMB. This round of financing was led by CDH Investment, with participation from CICC Qichen and existing shareholders, Volcanics Venture and Cash Capital. This round of financing will primarily be used for funding product R&D, establishing a clinical testing network, driving product registration efforts, constructing manufacturing facilities, improving clinical services, and increasing brand marketing. CEC Capital Group served as the exclusive financial advisor of Vision Medicals in this transaction.
Cancel

Date：2021-02
http://www.xinyucaifu.cn/index.php?a=shows&catid=34&id=828
Nubo Med, a leading provider of Internet of Things (IoT)-based integrated smart hospital software and hardware solutions, announced today the closing of a Series B financing round, raising several hundred of million RMB. The round was led by SAIF Partners
Cancel

Date：2021-01
http://www.xinyucaifu.cn/index.php?a=shows&catid=34&id=829
4Paradigm announced the closing of its Series D financing, raising $700 million. The round was led by Boyu Capital, Primavera Capital, and HOPU Investment, and included strategic investors such as the National Manufacturing Transformation Fund, China Deve
Cancel

Date：2021-01

CEC Capital Served as Financial Advisor